Developer docs
API playgroundTry for free, no card

Search company profiles

Omapix

Full company profile

uuid0009o4b

Namestring
Omapix
Legal namestring
OMAPiX GmbH
Websiteurl
omapix.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

OMAPiX is a privately held spatial omics services company founded in 2021 and headquartered in Leuven, Belgium, with operating subsidiaries in Frederick, Maryland (USA) and Langenfeld, Germany. The company was originally established as the European Spatial Biology Center and rebranded to OMAPiX in June 2023. It operates with 1–10 disclosed employees as an end-to-end contract research organization delivering spatial biology services to pharmaceutical/biotech organizations and academic research institutions across applications including cancer biology, biomarker discovery, immunology, neurology, cell and gene therapy, and rare diseases.

The core offering is platform-agnostic access to spatial omics technologies under a 'concierge' model: single-cell sequencing on 10x Chromium X, BD Rhapsody, Parse Biosciences and BioSkryb; spatial transcriptomics on 10x Visium CytAssist, Curio Seeker and Curio Trekker; in situ sequencing on 10x Xenium and Vizgen MERSCOPE; high-throughput sequencing on Element AVITI/AVITI24; and subcellular spatial proteomics via the Syncell Microscoop partnership. Custom bioinformatics services cover QC, expression normalization, segmentation, cell typing, cell-cell distances, cell-cell communication, niche analysis, and protein network analysis, with compute delivered through an Oracle Cloud Infrastructure collaboration that supplies GPU-accelerated analysis and a quarriable multimodal data layer for pharma customers.

OMAPiX generates revenue through professional services fees on a quote basis, tailored to each project's scope, technology mix, and analysis depth. The go-to-market is consultative enterprise field sales supported by content marketing via its website and direct engagement through LinkedIn and Twitter. The firm monetizes its position as a Certified Service Provider for Parse Biosciences and BioSkryb Genomics, and as a strategic partner for Vizgen, Resolve Biosciences, Ultivue, and Syncell, channeling end-user demand into its laboratories.

Short descriptiontext

OMAPiX is a privately held spatial omics services company delivering end-to-end spatial transcriptomics, proteomics, and single-cell multiomics solutions through multiple best-in-class technology platforms to pharmaceutical, biotech, and academic research customers across the US and Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersFrederick, United States
HQ citystring
Frederick
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spatial omics services, single-cell sequencing, spatial transcriptomics, contract research services, bioinformatics analysis
Industry4 codes
PRIMARYHLAGANAC
Single-Cell & Spatial Omics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAANAF
Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Spatial Omics Services
TypeProfessional Services
Description

OMAPiX generates revenue through providing comprehensive end-to-end spatial omics services including single cell sequencing, spatial transcriptomics, in situ sequencing, high throughput sequencing, and bioinformatics data analysis solutions. Services are tailored from scientific consultancy to data analysis, supporting projects across therapeutic areas and indications.

omapix.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Omapix is an end-to-end spatial omics services company that provides customized spatial biology solutions for pharmaceutical, biotech, and academic research customers. The company delivers services spanning scientific consultation, target/panel selection, sample processing, and custom bioinformatics data analysis, leveraging multiple complementary third-party spatial omics platforms (10x Genomics, Vizgen MERSCOPE, Curio, Parse Biosciences, BioSkryb, Element AVITI, Ultivue, Resolve Biosciences).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 100+ target RNAs detected in a single experiment with sub-cellular resolution
+3 more records
Product overview1 text field

OMAPiX is an end-to-end spatial omics services company offering a portfolio of technology platforms for single-cell sequencing, spatial transcriptomics, in situ sequencing, and high-throughput sequencing. The core offering includes 10x Genomics Chromium X, BD Rhapsody, BioSkryb, and Parse Biosciences for single-cell applications; 10x Visium CytAssist and Curio Seeker/Trekker for spatial transcriptomics; 10x Genomics Xenium and Vizgen MERSCOPE for in situ sequencing; and Element AVITI/AVITI24 for sequencing. Services are delivered through a concierge approach combining scientific consultation, target/panel selection, sample processing, and comprehensive bioinformatics and data analysis solutions. The company operates as a CRO providing customized spatial biology solutions for pharma, biotech, and academic research across applications including cancer biology, biomarker discovery, neurology, immunology, cell and gene therapy, and rare diseases.

Product and service6 records
1Single Cell Sequencing Services
CategorySingle-Cell Sequencing
Description

End-to-end single-cell sequencing services for pharma, biotech, and academic researchers using multiple complementary platforms (10x Genomics Chromium X, BD Rhapsody, BioSkryb, Parse Biosciences) supporting 3', 5' and immune profiling, ATAC, multiome, fixed, and nuclei applications with up to 1 million cells per single assay.

2Spatial Transcriptomics Services
CategorySpatial Transcriptomics
Description

Spatial transcriptomics services using 10x Visium CytAssist, Curio Seeker, and Curio Trekker platforms, providing unbiased whole-transcriptome analysis with sub-cellular resolution across fresh frozen and FFPE tissue samples for discovery and translational research applications.

3In Situ Sequencing Services
CategoryIn Situ Sequencing
Description

In situ sequencing services using 10x Genomics Xenium (up to 5,000 plex RNA detection) and Vizgen MERSCOPE (up to 1,000 plex RNA detection with protein co-detection) platforms, with FFPE and fresh frozen compatibility and optional post-processing protein detection (Akoya, IF, H&E).

4High Throughput Sequencing Services
CategoryHigh Throughput Sequencing
Description

High-throughput sequencing services using Element AVITI and AVITI24 platforms, featuring rolling cycle amplification for industry-leading quality scores, up to 2x300bp read lengths, full Illumina library compatibility without conversion reactions, and on-flow cell cytoprofiling (AVITI24).

5Bioinformatics & Data Analysis Solutions
CategoryBioinformatics
Description

Comprehensive bioinformatics support providing in-depth custom data analysis and integrated multimodal analysis including QC evaluations, expression normalization, segmentation, clustering/cell typing, cell-cell distances, cell-cell communication, niche analysis, and protein network analysis for spatial and single-cell datasets.

6Spatial Biology Services
CategoryContract Research Services
Description

End-to-end spatial omics service offering spanning scientific consultation, target/panel selection, sample processing, and standardized analysis, supporting spatial transcriptomics and proteomics with 100+ target RNAs per experiment at sub-cellular resolution, tissue heterogeneity mapping, and cell-typing for projects at any scale from discovery through clinical applications.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierMajorTypeTechnology or IntegrationAnnounced on2025-04-24
Description

OMAPiX is Syncell's first preferred service provider for their Microscoop technology - a first-of-its-kind solution for unbiased subcellular spatial proteomics. Through this collaboration, customers can get seamless, end-to-end Syncell Microscoop studies from cells or tissue samples.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-04-24
Description

MS Bioworks is Syncell's first preferred partner for mass spec and collaborates with OMAPiX in Syncell's preferred partner network to provide advanced mass spec service and analysis combined with Syncell's Microscoop spatial proteomics technology.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-12-23
Description

OMAPiX welcomed as a Certified Service Provider (CSP) in BioSkryb's CSP Program. BioSkryb Genomics provides single-cell multiomic technology including whole genome single cell analysis using Primary Template-directed Amplification (PTA). This partnership increases researchers' access to single-cell multiomics capabilities.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-11-20
Description

Strategic partnership making OMAPiX a Certified Service Provider (CSP) offering Parse Biosciences' innovative single-cell sequencing products. Parse Biosciences is a pioneer in scalable single-cell sequencing technology utilizing proprietary fixation and permeabilization method combined with combinatorial barcoding to generate high throughput and high-quality single-cell datasets. This enables researchers to access Parse Biosciences' technology without establishing protocols in their own laboratories.

5Oracle Cloud Infrastructure (OCI)
Strategic tierMajorTypeTechnology or IntegrationAnnounced on2024-04-04
Description

OMAPiX moved to Oracle Cloud Infrastructure to leverage powerful infrastructure and scalable GPU-accelerated computing for analyzing vast spatial biology datasets. Utilizing OCI's database technologies including Oracle Application Express (APEX) to build a quarriable registry for pharma customers. This partnership enables multimodal and multilayered data structures from clinical samples for identifying novel spatial signatures predictive of patient response to precision therapies.

omapix.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-06-26
Description

Strategic partnership for MERSCOPE Platform technology. Vizgen's MERSCOPE Platform enables spatial transcriptomics with up to 1,000 plex RNA detection and protein co-detection. OMAPiX scientists use Vizgen technology to provide customers with standardized, reliable, high-quality spatial transcriptomic data.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-06-26
Description

Partnership for Molecular Cartography technology. Resolve Biosciences enables translational research and drug development communities to apply spatially resolved, high-dimensional, multi-omic analysis at scale, especially for immune response studies.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-06-26
Description

Partnership for InSituPlex and UltiStacker technologies. Ultivue enables whole-slide spatial phenotyping for clinical biomarker development with digital pathology offerings, complementing other OMAPiX offerings.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Life sciences tools and services company with spatial biology reagents (RNAscope) and adjacent services capabilities. Comparable as a broader spatial biology ecosystem player with overlapping pharma research customers.

TypeDirect peer
Description

Developer of the MERSCOPE in situ sequencing platform — a core technology OMAPiX services under a strategic partnership. Direct peer given overlapping spatial transcriptomics services and shared pharma/academic customers.

TypeDirect peer
Description

Single-cell sequencing platform vendor for which OMAPiX is a Certified Service Provider. Directly comparable in single-cell services, with shared customers and overlapping CSP-driven service delivery model.

TypeDirect peer
Description

Global sequencing and multi-omics services company with spatial transcriptomics offerings. Comparable as a multi-platform omics services provider serving pharma and academic customers across multiple geographies.

TypeBroad incumbent
Description

Large incumbent genomics services business with broad portfolio that has expanded into spatial omics. Comparable as a scaled services provider serving overlapping pharma and academic customers, though broader in scope.

TypeDirect peer
Description

Molecular Cartography spatial multi-omics platform vendor and OMAPiX strategic partner. Comparable as a high-plex spatial omics service provider targeting translational pharma and academic research customers.

TypeDirect peer
Description

Spatial biology platform vendor (GeoMx, CosMx) now part of Bruker, with a services arm supporting pharma translational research. Comparable end-to-end spatial omics services offering for similar customer segments.

TypeDirect peer
Description

Provider of Chromium single-cell and Visium/Xenium spatial omics platforms that OMAPiX services on behalf of customers. Directly comparable technology vendor with adjacent service offerings and overlapping customer base in pharma and academic research.

TypeDirect peer
Description

Spatial transcriptomics platform vendor (Curio Seeker, Curio Trekker) and OMAPiX partner. Directly comparable single-cell and spatial services provider with similar biotech and academic customer base.

TypeDirect peer
Description

Genomics and spatial omics services CRO offering single-cell and spatial transcriptomics for pharma and academic customers. Closely comparable as a third-party spatial omics services provider with similar multi-platform positioning.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Omapix

Contract Research Servicesomapix.com

OMAPiX is a privately held spatial omics services company delivering end-to-end spatial transcriptomics, proteomics, and single-cell multiomics solutions through multiple best-in-class technology platforms to pharmaceutical, biotech, and academic research customers across the US and Europe.

What Omapix does

OMAPiX is a privately held spatial omics services company founded in 2021 and headquartered in Leuven, Belgium, with operating subsidiaries in Frederick, Maryland (USA) and Langenfeld, Germany. The company was originally established as the European Spatial Biology Center and rebranded to OMAPiX in June 2023. It operates with 1–10 disclosed employees as an end-to-end contract research organization delivering spatial biology services to pharmaceutical/biotech organizations and academic research institutions across applications including cancer biology, biomarker discovery, immunology, neurology, cell and gene therapy, and rare diseases.

The core offering is platform-agnostic access to spatial omics technologies under a 'concierge' model: single-cell sequencing on 10x Chromium X, BD Rhapsody, Parse Biosciences and BioSkryb; spatial transcriptomics on 10x Visium CytAssist, Curio Seeker and Curio Trekker; in situ sequencing on 10x Xenium and Vizgen MERSCOPE; high-throughput sequencing on Element AVITI/AVITI24; and subcellular spatial proteomics via the Syncell Microscoop partnership. Custom bioinformatics services cover QC, expression normalization, segmentation, cell typing, cell-cell distances, cell-cell communication, niche analysis, and protein network analysis, with compute delivered through an Oracle Cloud Infrastructure collaboration that supplies GPU-accelerated analysis and a quarriable multimodal data layer for pharma customers.

OMAPiX generates revenue through professional services fees on a quote basis, tailored to each project's scope, technology mix, and analysis depth. The go-to-market is consultative enterprise field sales supported by content marketing via its website and direct engagement through LinkedIn and Twitter. The firm monetizes its position as a Certified Service Provider for Parse Biosciences and BioSkryb Genomics, and as a strategic partner for Vizgen, Resolve Biosciences, Ultivue, and Syncell, channeling end-user demand into its laboratories.

Omapix firmographics

Firmographics
Name
Omapix
Legal name
OMAPiX GmbH
Website
https://omapix.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
OMAPiX is a privately held spatial omics services company delivering end-to-end spatial transcriptomics, proteomics, and single-cell multiomics solutions through multiple best-in-class technology platforms to pharmaceutical, biotech, and academic research customers across the US and Europe.
Ownership category
akta.pro rank

Omapix industry classification

Industry
Product category
Contract Research Services
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGANAC
Single-Cell & Spatial Omics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAANAF
Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Spatial omics services
  • Single-cell sequencing
  • Spatial transcriptomics
  • Contract research services
  • Bioinformatics analysis

Where Omapix is headquartered

Location

Headquarters

HQ city
Frederick
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Omapix business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Spatial Omics Services: OMAPiX generates revenue through providing comprehensive end-to-end spatial omics services including single cell sequencing, spatial transcriptomics, in situ sequencing, high throughput sequencing, and bioinformatics data analysis solutions. Services are tailored from scientific consultancy to data analysis, supporting projects across therapeutic areas and indications.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Omapix product offering

Product offering

Core offering

Omapix is an end-to-end spatial omics services company that provides customized spatial biology solutions for pharmaceutical, biotech, and academic research customers. The company delivers services spanning scientific consultation, target/panel selection, sample processing, and custom bioinformatics data analysis, leveraging multiple complementary third-party spatial omics platforms (10x Genomics, Vizgen MERSCOPE, Curio, Parse Biosciences, BioSkryb, Element AVITI, Ultivue, Resolve Biosciences).

Product overview

OMAPiX is an end-to-end spatial omics services company offering a portfolio of technology platforms for single-cell sequencing, spatial transcriptomics, in situ sequencing, and high-throughput sequencing. The core offering includes 10x Genomics Chromium X, BD Rhapsody, BioSkryb, and Parse Biosciences for single-cell applications; 10x Visium CytAssist and Curio Seeker/Trekker for spatial transcriptomics; 10x Genomics Xenium and Vizgen MERSCOPE for in situ sequencing; and Element AVITI/AVITI24 for sequencing. Services are delivered through a concierge approach combining scientific consultation, target/panel selection, sample processing, and comprehensive bioinformatics and data analysis solutions. The company operates as a CRO providing customized spatial biology solutions for pharma, biotech, and academic research across applications including cancer biology, biomarker discovery, neurology, immunology, cell and gene therapy, and rare diseases.

Differentiator

Problem solved

Functional benefit

Products and services

  • Single Cell Sequencing Services End-to-end single-cell sequencing services for pharma, biotech, and academic researchers using multiple complementary platforms (10x Genomics Chromium X, BD Rhapsody, BioSkryb, Parse Biosciences) supporting 3', 5' and immune profiling, ATAC, multiome, fixed, and nuclei applications with up to 1 million cells per single assay.
  • Spatial Transcriptomics Services Spatial transcriptomics services using 10x Visium CytAssist, Curio Seeker, and Curio Trekker platforms, providing unbiased whole-transcriptome analysis with sub-cellular resolution across fresh frozen and FFPE tissue samples for discovery and translational research applications.
  • In Situ Sequencing Services In situ sequencing services using 10x Genomics Xenium (up to 5,000 plex RNA detection) and Vizgen MERSCOPE (up to 1,000 plex RNA detection with protein co-detection) platforms, with FFPE and fresh frozen compatibility and optional post-processing protein detection (Akoya, IF, H&E).
  • High Throughput Sequencing Services High-throughput sequencing services using Element AVITI and AVITI24 platforms, featuring rolling cycle amplification for industry-leading quality scores, up to 2x300bp read lengths, full Illumina library compatibility without conversion reactions, and on-flow cell cytoprofiling (AVITI24).
  • Bioinformatics & Data Analysis Solutions Comprehensive bioinformatics support providing in-depth custom data analysis and integrated multimodal analysis including QC evaluations, expression normalization, segmentation, clustering/cell typing, cell-cell distances, cell-cell communication, niche analysis, and protein network analysis for spatial and single-cell datasets.
  • Spatial Biology Services End-to-end spatial omics service offering spanning scientific consultation, target/panel selection, sample processing, and standardized analysis, supporting spatial transcriptomics and proteomics with 100+ target RNAs per experiment at sub-cellular resolution, tissue heterogeneity mapping, and cell-typing for projects at any scale from discovery through clinical applications.

Quantifiable outcome

  • 100+ target RNAs detected in a single experiment with sub-cellular resolution
  • +3 more outcomes

Companies that use Omapix

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Omapix technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Omapix partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered major and core.

  • SyncellmajorTechnology or Integration · 24 April 2025OMAPiX is Syncell's first preferred service provider for their Microscoop technology - a first-of-its-kind solution for unbiased subcellular spatial proteomics. Through this collaboration, customers can get seamless, end-to-end Syncell Microscoop studies from cells or tissue samples.
  • MS BioworksmajorStrategic or Co-development Partner · 24 April 2025MS Bioworks is Syncell's first preferred partner for mass spec and collaborates with OMAPiX in Syncell's preferred partner network to provide advanced mass spec service and analysis combined with Syncell's Microscoop spatial proteomics technology.
  • BioSkryb GenomicscoreTechnology or Integration · 23 December 2024OMAPiX welcomed as a Certified Service Provider (CSP) in BioSkryb's CSP Program. BioSkryb Genomics provides single-cell multiomic technology including whole genome single cell analysis using Primary Template-directed Amplification (PTA). This partnership increases researchers' access to single-cell multiomics capabilities.
  • Parse BiosciencescoreTechnology or Integration · 20 November 2024Strategic partnership making OMAPiX a Certified Service Provider (CSP) offering Parse Biosciences' innovative single-cell sequencing products. Parse Biosciences is a pioneer in scalable single-cell sequencing technology utilizing proprietary fixation and permeabilization method combined with combinatorial barcoding to generate high throughput and high-quality single-cell datasets. This enables researchers to access Parse Biosciences' technology without establishing protocols in their own laboratories.
  • Oracle Cloud Infrastructure (OCI)majorTechnology or Integration · 4 April 2024OMAPiX moved to Oracle Cloud Infrastructure to leverage powerful infrastructure and scalable GPU-accelerated computing for analyzing vast spatial biology datasets. Utilizing OCI's database technologies including Oracle Application Express (APEX) to build a quarriable registry for pharma customers. This partnership enables multimodal and multilayered data structures from clinical samples for identifying novel spatial signatures predictive of patient response to precision therapies.
  • VizgencoreTechnology or Integration · 26 June 2023Strategic partnership for MERSCOPE Platform technology. Vizgen's MERSCOPE Platform enables spatial transcriptomics with up to 1,000 plex RNA detection and protein co-detection. OMAPiX scientists use Vizgen technology to provide customers with standardized, reliable, high-quality spatial transcriptomic data.
  • Resolve BiosciencescoreTechnology or Integration · 26 June 2023Partnership for Molecular Cartography technology. Resolve Biosciences enables translational research and drug development communities to apply spatially resolved, high-dimensional, multi-omic analysis at scale, especially for immune response studies.
  • UltivuecoreTechnology or Integration · 26 June 2023Partnership for InSituPlex and UltiStacker technologies. Ultivue enables whole-slide spatial phenotyping for clinical biomarker development with digital pathology offerings, complementing other OMAPiX offerings.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Omapix competitors and assessment

Company assessment

Broad incumbents

  • Bio-Techne: Life sciences tools and services company with spatial biology reagents (RNAscope) and adjacent services capabilities. Comparable as a broader spatial biology ecosystem player with overlapping pharma research customers.
  • Eurofins Genomics: Large incumbent genomics services business with broad portfolio that has expanded into spatial omics. Comparable as a scaled services provider serving overlapping pharma and academic customers, though broader in scope.

Direct peers

  • Vizgen: Developer of the MERSCOPE in situ sequencing platform — a core technology OMAPiX services under a strategic partnership. Direct peer given overlapping spatial transcriptomics services and shared pharma/academic customers.
  • Parse Biosciences: Single-cell sequencing platform vendor for which OMAPiX is a Certified Service Provider. Directly comparable in single-cell services, with shared customers and overlapping CSP-driven service delivery model.
  • Novogene: Global sequencing and multi-omics services company with spatial transcriptomics offerings. Comparable as a multi-platform omics services provider serving pharma and academic customers across multiple geographies.
  • Resolve Biosciences: Molecular Cartography spatial multi-omics platform vendor and OMAPiX strategic partner. Comparable as a high-plex spatial omics service provider targeting translational pharma and academic research customers.
  • NanoString Technologies (Bruker Spatial Biology): Spatial biology platform vendor (GeoMx, CosMx) now part of Bruker, with a services arm supporting pharma translational research. Comparable end-to-end spatial omics services offering for similar customer segments.
  • 10x Genomics: Provider of Chromium single-cell and Visium/Xenium spatial omics platforms that OMAPiX services on behalf of customers. Directly comparable technology vendor with adjacent service offerings and overlapping customer base in pharma and academic research.
  • Curio Bioscience: Spatial transcriptomics platform vendor (Curio Seeker, Curio Trekker) and OMAPiX partner. Directly comparable single-cell and spatial services provider with similar biotech and academic customer base.
  • CD Genomics: Genomics and spatial omics services CRO offering single-cell and spatial transcriptomics for pharma and academic customers. Closely comparable as a third-party spatial omics services provider with similar multi-platform positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Omapix social profiles

Digital presence

Omapix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Omapix leadership team

Management profile

Number of profiles

Profiles4 records

Omapix funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Omapix M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Omapix

What does Omapix do?

Omapix is an end-to-end spatial omics services company that provides customized spatial biology solutions for pharmaceutical, biotech, and academic research customers. The company delivers services spanning scientific consultation, target/panel selection, sample processing, and custom bioinformatics data analysis, leveraging multiple complementary third-party spatial omics platforms (10x Genomics, Vizgen MERSCOPE, Curio, Parse Biosciences, BioSkryb, Element AVITI, Ultivue, Resolve Biosciences).

Is Omapix a public or private company?

Omapix is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Omapix founded?

Omapix was founded in 2021. It employs 1 to 10 people.

Where is Omapix based?

Omapix is headquartered in Frederick, United States, in the North America region.

How does Omapix make money?

One revenue line is on record: spatial Omics Services.

Who are Omapix's main competitors?

Broad incumbents on record are Bio-Techne and Eurofins Genomics. Direct peers are Vizgen, Parse Biosciences, Novogene, Resolve Biosciences, NanoString Technologies (Bruker Spatial Biology), 10x Genomics, Curio Bioscience and CD Genomics.

Does Omapix have an API?

No public API is recorded for Omapix.

What industry is Omapix in?

Omapix's product category is Contract Research Services. Its primary akta.pro industry code is HLAGANAC, Single-Cell & Spatial Omics Services, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals